SubscribeElsewhere on HealthThreads: Prostate cancer | Pancreatic cancer | Thyroid cancer | Breast cancer | Lymphoma | Menopause | Colorectal cancer | Endometrial cancer |
# 4 Blogger
sev.prnewswire.com
sev.prnewswire.com (sev.prnewswire.com) has great Ovarian cancer news, photos, videos and more
Wednesday, Jun 3
Gene Network Sciences Announces Cancer Collaboration with ... - PR Newswire
Runowicz and Neyarapally are also, together with colleagues Drs. Molly Brewer and Iya Khalil, preparing a scientific publication regarding ovarian cancer treatment and the use of computational modeling capabilities such as GNS's supercomputing-driven ...
Tuesday, May 19
Morphotek(R), Inc and Lonza Group Ltd Enter Into Manufacturing ... - PR Newswire
Through its technology and collaborations, the company remains committed to bringing a new treatment option for patients with ovarian cancer. Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. ...
Thursday, May 14
Moffitt Cancer Center Signs Licensing Agreement with Frantz ... - PR Newswire
Each year, 26000 women in the United States are diagnosed with ovarian cancer, and 16000 die of the disease. There is no effective screening tool or method for accurate diagnosis without surgery. Even among symptomatic women, surgery is the only ...
Wednesday, May 13
Video: Liberate The Breast Cancer Genes - PR Newswire
NEW YORK, May 13 /PRNewswire/ -- Breast cancer survivor Genae Girard underwent genetic testing to determine whether she's also at risk for ovarian cancer and should have her ovaries removed. But the test didn't come with a second opinion -- a problem ...
Tuesday, May 12
Lilly Set to Unveil More Than 50 Studies at ASCO 2009 - PR Newswire
PR Newswire (press release), NY GEMZAR is indicated in combination with carboplatin (another type of chemotherapy) for the patient with ovarian cancer that has returned at least 6 months after the patient had finished platinum-based therapy. GEMZAR is indicated as a single agent ...
Wednesday, May 6
Video: Research in Women's Cancers Leading the Personalized ... - PR Newswire
Dr. Johnathan Lancaster, an internationally known ovarian cancer researcher, is Director of The Center for Women's Oncology at Moffitt Cancer Center: "We've now reached a point in cancer research and treatment that is really very exciting. ...
Tuesday, May 5
Women's Gynecological Exams: Another Victim of the Troubled Economy? - PR Newswire
Ovarian cancer affects 20000 women annually and is responsible for the deaths of 15000 each year. Older women are at highest risk. Additionally, about two-thirds of ovarian cancer deaths occur in women aged 55 and over and about 25 percent occur in ...
Friday, Apr 24
NFGC Conducts Multi-Institutional Research Project in Ovarian Cancer - PR Newswire
For the first phase of the project, the group will use a biologically-driven approach to characterize gene expression and oncogene activation of copy number and point mutations in preclinical models by profiling ovarian cancer cells and ovarian cancer ...
Wednesday, Apr 15
Cequent tkRNAi Technology to be Presented at the Centennial ... - PR Newswire
PR Newswire (press release), NY Here, Professor Lage demonstrates the effectiveness of using tkRNAi against an important multidrug resistance mechanism seen in solid cancers such as gastric carcinoma, ovarian cancer, and others. An early-stage biopharmaceutical company, ...
Wednesday, Apr 1
New Report Shows Record Number of Medicines in Development to ... - PR Newswire
kidney cancer, ovarian cancer, pancreatic cancer, skin cancer, and others. The medicines represent many cutting-edge approaches, including a drug that delivers a synthetic version of a substance derived from scorpions directly to brain tumor cells; ...
